Central govt refutes reports of Covid vaccine shortage in Maharashtra

Refuting media reports on vaccine shortage in Maharashtra, the Health Ministry said the state had over 24 lakh unutilised doses of Covaxin and received an additional 6.35 lakh doses on Friday.

vaccine
Press Trust of India New Delhi
1 min read Last Updated : Jan 14 2022 | 4:38 PM IST

Refuting media reports on COVID-19 vaccine shortage in Maharashtra, the Health Ministry said the state had over 24 lakh unutilised doses of Covaxin and received an additional 6.35 lakh doses on Friday.

According to the media reports, the state government is unable to increase the pace of vaccination due to a shortage in vaccine availability.

"As per their weekly consumption data available on Co-WIN, the average consumption by Maharashtra for Covaxin to cover the eligible beneficiaries for 15-17 years and for precaution dose is almost 2.94 lakh doses per day. Therefore, the state has adequate vaccine doses for about 10 days to cover the eligible beneficiaries with Covaxin," the ministry said in a statement.

"Furthermore, for Covishield, the state has 1.24 crore unutilised and balance doses available as on date. With an average consumption of 3.57 lakhs per day, this will sustain for more than 30 days for the beneficiaries to be vaccinated using the vaccine," it said.

Hence, the media reports are not factually correct and do not reflect the correct picture of the available stock of balance and unutilised Covid vaccine doses with Maharashtra, the ministry said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineMaharashtracentral government

First Published: Jan 14 2022 | 4:38 PM IST

Next Story